New Frontier: FDA Announces Draft Plausible Mechanism Framework for Individualized Ultra-Rare Disease Therapies

Key Takeaways – FDA has proposed a Plausible Mechanism Framework for ultra-rare disease therapies. The February 2026 draft guidance explains how sponsors may demonstrate safety and effectiveness when traditional randomized controlled trials are impracticable due to extremely small patient populations….
By: Arnall Golden Gregory LLP